STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G/A

APLT Schedule 13G/A filing by T. Rowe Price Investment Management

T. Rowe Price Investment Management reported beneficial ownership of 15.6M shares, representing 12% of APPLIED THERAPEUTICS INC in this filing.

FiledMay 7, 2025
Ownership dateApr 30, 2025
Reported shares15.6M
Reported ownership12%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 15.6M
Shared voting power 15.6M
Sole dispositive power 15.6M
Shared dispositive power 15.6M
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
T. Rowe Price Investment Management
CIK
CIK0001897612
Accession
0001897612-25-000125
Form
Schedule 13G/A
Open SEC filing View APLT ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →